IMS Health Holdings Reaches New 1-Year High at $28.38 (IMS)
Shares of IMS Health Holdings (NYSE:IMS) hit a new 52-week high on Tuesday , American Banking News.com reports. The company traded as high as $28.38 and last traded at $27.87, with a volume of 149,186 shares changing hands. The stock had previously closed at $27.90.
Several analysts have recently commented on the stock. Analysts at Goldman Sachs raised their price target on shares of IMS Health Holdings from $25.00 to $26.00 in a research note on Tuesday, August 5th. Separately, analysts at Drexel Hamilton initiated coverage on shares of IMS Health Holdings in a research note on Tuesday, August 5th. They set a “buy” rating and a $30.00 price target on the stock. Finally, analysts at Mizuho raised their price target on shares of IMS Health Holdings from $29.00 to $31.00 in a research note on Thursday, July 24th. They now have a “buy” rating on the stock. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $27.91.
The stock’s 50-day moving average is $26.79 and its 200-day moving average is $25.11. The company’s market cap is $9.370 billion.
IMS Health Holdings (NYSE:IMS) last posted its quarterly earnings results on Thursday, July 24th. The company reported $0.39 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.37 by $0.02. The company had revenue of $662.00 million for the quarter, compared to the consensus estimate of $654.92 million. IMS Health Holdings’s revenue was up 6.1% compared to the same quarter last year. On average, analysts predict that IMS Health Holdings will post $1.38 earnings per share for the current fiscal year.
IMS Health Holdings, Inc (NYSE:IMS) is a global information and technology services company providing solutions to the clients in the healthcare industry.